Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 128

1.

All-Purpose Containers? Lipid-Binding Protein - Drug Interactions.

Beringhelli T, Gianazza E, Maggioni D, Scanu S, Parravicini C, Sensi C, Monaco HL, Eberini I.

PLoS One. 2015 Jul 13;10(7):e0132096. doi: 10.1371/journal.pone.0132096. eCollection 2015.

2.

Oxysterols act as promiscuous ligands of class-A GPCRs: in silico molecular modeling and in vitro validation.

Sensi C, Daniele S, Parravicini C, Zappelli E, Russo V, Trincavelli ML, Martini C, Abbracchio MP, Eberini I.

Cell Signal. 2014 Dec;26(12):2614-20. doi: 10.1016/j.cellsig.2014.08.003. Epub 2014 Aug 22.

PMID:
25152366
3.

A computational approach to evaluate the androgenic affinity of iprodione, procymidone, vinclozolin and their metabolites.

Galli CL, Sensi C, Fumagalli A, Parravicini C, Marinovich M, Eberini I.

PLoS One. 2014 Aug 11;9(8):e104822. doi: 10.1371/journal.pone.0104822. eCollection 2014.

4.

Primary gastric Merkel cell carcinoma harboring DNA polyomavirus: first description of an unusual high-grade neuroendocrine carcinoma.

Capella C, Marando A, Longhi E, Bernasconi B, Finzi G, Parravicini C, Sessa F, La Rosa S.

Hum Pathol. 2014 Jun;45(6):1310-4. doi: 10.1016/j.humpath.2014.01.019. Epub 2014 Feb 6.

PMID:
24709111
5.

Ventral tegmental area/substantia nigra and prefrontal cortex rodent organotypic brain slices as an integrated model to study the cellular changes induced by oxygen/glucose deprivation and reperfusion: effect of neuroprotective agents.

Colombo L, Parravicini C, Lecca D, Dossi E, Heine C, Cimino M, Wanke E, Illes P, Franke H, Abbracchio MP.

Neurochem Int. 2014 Jan;66:43-54. doi: 10.1016/j.neuint.2014.01.008. Epub 2014 Jan 23.

PMID:
24463100
6.

Antibodies are forever: a study using 12-26-year-old expired antibodies.

Argentieri MC, Pilla D, Vanzati A, Lonardi S, Facchetti F, Doglioni C, Parravicini C, Cattoretti G.

Histopathology. 2013 Dec;63(6):869-76. doi: 10.1111/his.12225. Epub 2013 Sep 16.

PMID:
24102865
7.

Human herpesvirus 8+ polyclonal IgMλ B-cell lymphocytosis mimicking plasmablastic leukemia/lymphoma in HIV-infected patients.

Oksenhendler E, Boutboul D, Beldjord K, Meignin V, de Labarthe A, Fieschi C, Dossier A, Agbalika F, Parravicini C, Tosato G, Gérard L, Galicier L.

Eur J Haematol. 2013 Dec;91(6):497-503. doi: 10.1111/ejh.12191. Epub 2013 Sep 18.

PMID:
23992152
8.

Changes of the GPR17 receptor, a new target for neurorepair, in neurons and glial cells in patients with traumatic brain injury.

Franke H, Parravicini C, Lecca D, Zanier ER, Heine C, Bremicker K, Fumagalli M, Rosa P, Longhi L, Stocchetti N, De Simoni MG, Weber M, Abbracchio MP.

Purinergic Signal. 2013 Sep;9(3):451-62. doi: 10.1007/s11302-013-9366-3. Epub 2013 Jun 26.

9.

Trends and predictors of non-AIDS-defining cancers in men and women with HIV infection: a single-institution retrospective study before and after the introduction of HAART.

Franzetti M, Adorni F, Parravicini C, Vergani B, Antinori S, Milazzo L, Galli M, Ridolfo AL.

J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):414-20. doi: 10.1097/QAI.0b013e318282a189.

PMID:
23274934
10.

Gastrointestinal cancers reactive for the PAb416 antibody against JCV/SV40 T-Ag lack JCV DNA sequences while showing a distinctive pathologic profile.

Chiaravalli AM, Longhi E, Vigetti D, De Stefano FI, Deleonibus S, Capella C, Solcia E, Parravicini C.

J Clin Pathol. 2013 Jan;66(1):44-9. doi: 10.1136/jclinpath-2012-200963. Epub 2012 Sep 25.

PMID:
23012397
11.

Class A GPCRs: a multifaceted reality.

Parravicini C, Sensi C, Eberini I.

Purinergic Signal. 2011 Sep;7(3):279-81. doi: 10.1007/s11302-011-9243-x. No abstract available.

12.

In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases.

Eberini I, Daniele S, Parravicini C, Sensi C, Trincavelli ML, Martini C, Abbracchio MP.

J Comput Aided Mol Des. 2011 Aug;25(8):743-52. doi: 10.1007/s10822-011-9455-8. Epub 2011 Jul 9.

PMID:
21744154
13.

Liver-related factors associated with low vitamin D levels in HIV and HIV/HCV coinfected patients and comparison to general population.

Milazzo L, Mazzali C, Bestetti G, Longhi E, Foschi A, Viola A, Vago T, Galli M, Parravicini C, Antinori S.

Curr HIV Res. 2011 Apr;9(3):186-93.

PMID:
21585333
14.

Phenotypic changes, signaling pathway, and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation.

Fumagalli M, Daniele S, Lecca D, Lee PR, Parravicini C, Fields RD, Rosa P, Antonucci F, Verderio C, Trincavelli ML, Bramanti P, Martini C, Abbracchio MP.

J Biol Chem. 2011 Mar 25;286(12):10593-604. doi: 10.1074/jbc.M110.162867. Epub 2011 Jan 5.

15.

Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor.

Calleri E, Ceruti S, Cristalli G, Martini C, Temporini C, Parravicini C, Volpini R, Daniele S, Caccialanza G, Lecca D, Lambertucci C, Trincavelli ML, Marucci G, Wainer IW, Ranghino G, Fantucci P, Abbracchio MP, Massolini G.

J Med Chem. 2010 May 13;53(9):3489-501. doi: 10.1021/jm901691y.

PMID:
20394377
16.

Forced unbinding of GPR17 ligands from wild type and R255I mutant receptor models through a computational approach.

Parravicini C, Abbracchio MP, Fantucci P, Ranghino G.

BMC Struct Biol. 2010 Mar 16;10:8. doi: 10.1186/1472-6807-10-8.

17.

Trends in the postmortem diagnosis of opportunistic invasive fungal infections in patients with AIDS: a retrospective study of 1,630 autopsies performed between 1984 and 2002.

Antinori S, Nebuloni M, Magni C, Fasan M, Adorni F, Viola A, Corbellino M, Galli M, Vago G, Parravicini C, Ridolfo AL.

Am J Clin Pathol. 2009 Aug;132(2):221-7. doi: 10.1309/AJCPRAAE8LZ7DTNE.

18.

Is real-time polymerase chain reaction (PCR) more useful than a conventional PCR for the clinical management of leishmaniasis?

Antinori S, Calattini S, Piolini R, Longhi E, Bestetti G, Cascio A, Parravicini C, Corbellino M.

Am J Trop Med Hyg. 2009 Jul;81(1):46-51.

19.

AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy.

Antinori S, Ridolfo A, Fasan M, Magni C, Galimberti L, Milazzo L, Sollima S, Adorni F, Giuliani G, Galli M, Corbellino M, Parravicini C.

HIV Med. 2009 Jan;10(1):6-11. doi: 10.1111/j.1468-1293.2008.00645.x.

PMID:
19125961
20.

A third genotype of the human parvovirus PARV4 in sub-Saharan Africa.

Simmonds P, Douglas J, Bestetti G, Longhi E, Antinori S, Parravicini C, Corbellino M.

J Gen Virol. 2008 Sep;89(Pt 9):2299-302. doi: 10.1099/vir.0.2008/001180-0.

PMID:
18753240
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk